University of Michigan researchers have developed an implantable system that could predict type 1 diabetes before symptoms appear. By tracking subtle changes in the immune system, the device may help doctors know when to intervene. The findings point to a future where high-risk individuals can be monitored more closely, though the full impact is still unfolding.
